156 related articles for article (PubMed ID: 24038832)
1. Rescue of functional CFTR channels in cystic fibrosis: a dramatic multivalent effect using iminosugar cluster-based correctors.
Compain P; Decroocq C; Joosten A; de Sousa J; Rodríguez-Lucena D; Butters TD; Bertrand J; Clément R; Boinot C; Becq F; Norez C
Chembiochem; 2013 Oct; 14(15):2050-8. PubMed ID: 24038832
[TBL] [Abstract][Full Text] [Related]
2. Correctors of the basic trafficking defect of the mutant F508del-CFTR that causes cystic fibrosis.
Birault V; Solari R; Hanrahan J; Thomas DY
Curr Opin Chem Biol; 2013 Jun; 17(3):353-60. PubMed ID: 23711435
[TBL] [Abstract][Full Text] [Related]
3. An overview on chemical structures as ΔF508-CFTR correctors.
Spanò V; Montalbano A; Carbone A; Scudieri P; Galietta LJV; Barraja P
Eur J Med Chem; 2019 Oct; 180():430-448. PubMed ID: 31326599
[TBL] [Abstract][Full Text] [Related]
4. A chemical corrector modifies the channel function of F508del-CFTR.
Kim Chiaw P; Wellhauser L; Huan LJ; Ramjeesingh M; Bear CE
Mol Pharmacol; 2010 Sep; 78(3):411-8. PubMed ID: 20501743
[TBL] [Abstract][Full Text] [Related]
5. Specific rescue of cystic fibrosis transmembrane conductance regulator processing mutants using pharmacological chaperones.
Wang Y; Bartlett MC; Loo TW; Clarke DM
Mol Pharmacol; 2006 Jul; 70(1):297-302. PubMed ID: 16624886
[TBL] [Abstract][Full Text] [Related]
6. Dynasore inhibits removal of wild-type and DeltaF508 cystic fibrosis transmembrane conductance regulator (CFTR) from the plasma membrane.
Young A; Gentzsch M; Abban CY; Jia Y; Meneses PI; Bridges RJ; Bradbury NA
Biochem J; 2009 Jul; 421(3):377-85. PubMed ID: 19442237
[TBL] [Abstract][Full Text] [Related]
7. Correcting CFTR folding defects by small-molecule correctors to cure cystic fibrosis.
Mijnders M; Kleizen B; Braakman I
Curr Opin Pharmacol; 2017 Jun; 34():83-90. PubMed ID: 29055231
[TBL] [Abstract][Full Text] [Related]
8. Capturing the Direct Binding of CFTR Correctors to CFTR by Using Click Chemistry.
Sinha C; Zhang W; Moon CS; Actis M; Yarlagadda S; Arora K; Woodroofe K; Clancy JP; Lin S; Ziady AG; Frizzell R; Fujii N; Naren AP
Chembiochem; 2015 Sep; 16(14):2017-22. PubMed ID: 26227551
[TBL] [Abstract][Full Text] [Related]
9. Novel pharmacological strategies to treat cystic fibrosis.
Hanrahan JW; Sampson HM; Thomas DY
Trends Pharmacol Sci; 2013 Feb; 34(2):119-25. PubMed ID: 23380248
[TBL] [Abstract][Full Text] [Related]
10. The cystic fibrosis V232D mutation inhibits CFTR maturation by disrupting a hydrophobic pocket rather than formation of aberrant interhelical hydrogen bonds.
Loo TW; Clarke DM
Biochem Pharmacol; 2014 Mar; 88(1):46-57. PubMed ID: 24412276
[TBL] [Abstract][Full Text] [Related]
11. The cystic fibrosis transmembrane regulator forms macromolecular complexes with PDZ domain scaffold proteins.
Guggino WB
Proc Am Thorac Soc; 2004; 1(1):28-32. PubMed ID: 16113408
[TBL] [Abstract][Full Text] [Related]
12. Rescue of functional delF508-CFTR channels in cystic fibrosis epithelial cells by the alpha-glucosidase inhibitor miglustat.
Norez C; Noel S; Wilke M; Bijvelds M; Jorna H; Melin P; DeJonge H; Becq F
FEBS Lett; 2006 Apr; 580(8):2081-6. PubMed ID: 16546175
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationship of aminoarylthiazole derivatives as correctors of the chloride transport defect in cystic fibrosis.
Pesce E; Bellotti M; Liessi N; Guariento S; Damonte G; Cichero E; Galatini A; Salis A; Gianotti A; Pedemonte N; Zegarra-Moran O; Fossa P; Galietta LJ; Millo E
Eur J Med Chem; 2015 Jun; 99():14-35. PubMed ID: 26041577
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological induction of CFTR function in patients with cystic fibrosis: mutation-specific therapy.
Kerem E
Pediatr Pulmonol; 2005 Sep; 40(3):183-96. PubMed ID: 15880796
[TBL] [Abstract][Full Text] [Related]
15. VX-809 and related corrector compounds exhibit secondary activity stabilizing active F508del-CFTR after its partial rescue to the cell surface.
Eckford PD; Ramjeesingh M; Molinski S; Pasyk S; Dekkers JF; Li C; Ahmadi S; Ip W; Chung TE; Du K; Yeger H; Beekman J; Gonska T; Bear CE
Chem Biol; 2014 May; 21(5):666-78. PubMed ID: 24726831
[TBL] [Abstract][Full Text] [Related]
16. Ibuprofen rescues mutant cystic fibrosis transmembrane conductance regulator trafficking.
Carlile GW; Robert R; Goepp J; Matthes E; Liao J; Kus B; Macknight SD; Rotin D; Hanrahan JW; Thomas DY
J Cyst Fibros; 2015 Jan; 14(1):16-25. PubMed ID: 24974227
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological rescue of the mutant cystic fibrosis transmembrane conductance regulator (CFTR) detected by use of a novel fluorescence platform.
Holleran JP; Glover ML; Peters KW; Bertrand CA; Watkins SC; Jarvik JW; Frizzell RA
Mol Med; 2012 May; 18(1):685-96. PubMed ID: 22396015
[TBL] [Abstract][Full Text] [Related]
18. N- and C-alkylation of seven-membered iminosugars generates potent glucocerebrosidase inhibitors and F508del-CFTR correctors.
Désiré J; Mondon M; Fontelle N; Nakagawa S; Hirokami Y; Adachi I; Iwaki R; Fleet GW; Alonzi DS; Twigg G; Butters TD; Bertrand J; Cendret V; Becq F; Norez C; Marrot J; Kato A; Blériot Y
Org Biomol Chem; 2014 Nov; 12(44):8977-96. PubMed ID: 25277226
[TBL] [Abstract][Full Text] [Related]
19. Turnover of the cystic fibrosis transmembrane conductance regulator (CFTR): slow degradation of wild-type and delta F508 CFTR in surface membrane preparations of immortalized airway epithelial cells.
Wei X; Eisman R; Xu J; Harsch AD; Mulberg AE; Bevins CL; Glick MC; Scanlin TF
J Cell Physiol; 1996 Aug; 168(2):373-84. PubMed ID: 8707873
[TBL] [Abstract][Full Text] [Related]
20. Correctors promote folding of the CFTR in the endoplasmic reticulum.
Loo TW; Bartlett MC; Clarke DM
Biochem J; 2008 Jul; 413(1):29-36. PubMed ID: 18361776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]